Around 50% of postmenopausal women in Europe have vitamin D levels below the threshold considered sufficient for good health. This isn’t a coincidence. Menopause changes how the body absorbs, metabolises, and uses vitamin D — and the consequences affect everything from bone density to mood to immune function.
Understanding what vitamin D does during this phase of life, and how much you actually need, is more practical than most articles on the subject suggest.
Why menopause affects vitamin D status
Several mechanisms converge to make vitamin D deficiency more likely after menopause.
First, oestrogen plays a role in vitamin D metabolism. Oestrogen stimulates the production of the enzyme that converts vitamin D into its active form (calcitriol) in the kidneys. As oestrogen declines during and after menopause, this conversion becomes less efficient — meaning that even the same dietary and sun-derived vitamin D intake produces less active vitamin D in the body.
Second, age-related changes compound this. The skin’s capacity to synthesise vitamin D3 from UVB light declines with age, with older adults producing roughly 25–50% less D3 per unit of sun exposure than younger adults. In the UK, this matters especially between October and March, when UVB levels are insufficient for D3 synthesis in anyone — leaving dietary and supplement sources as the only reliable options.
Third, kidney function declines with age, and the kidneys are responsible for the final activation step that converts 25(OH)D to calcitriol. Reduced kidney efficiency further limits the body’s ability to make full use of the vitamin D it has.
Vitamin D and bone health during menopause
Bone loss is one of the most significant health concerns associated with menopause, and vitamin D is central to the biology of why it happens and how to reduce it.
Oestrogen inhibits osteoclasts — the cells that break down bone. When oestrogen declines at menopause, osteoclast activity increases and bone resorption accelerates. Bone mineral density can drop by 1–3% per year in the first 5–10 years after menopause, increasing the risk of osteoporosis and fractures. In the UK, approximately one in two women over 50 will experience an osteoporotic fracture in their lifetime.
Vitamin D is essential for calcium absorption from the gut. Without adequate vitamin D, even a calcium-rich diet results in poor calcium uptake — and insufficient calcium means the body draws it from bone instead. Studies consistently show that postmenopausal women with lower vitamin D levels have lower bone mineral density and higher fracture rates than those with adequate levels.
A Cochrane review found that vitamin D supplementation combined with calcium significantly reduced fracture risk in postmenopausal women and older adults — one of the more robust findings in nutritional research. However, the combination with calcium matters: D3 alone provides less benefit for bone than D3 alongside adequate calcium intake.
Vitamin K2 is also part of this picture. K2 activates osteocalcin, the protein that anchors calcium into bone matrix, and Matrix Gla Protein, which prevents calcium from depositing in arteries. Taking D3 with K2 addresses both the absorption of calcium and its proper distribution — something D3 alone cannot achieve. This combination is particularly relevant for postmenopausal women given the accelerated bone loss in this period. See our article on vitamin D3 and K2 for a full explanation of how they work together.
Vitamin D and mood during menopause
Depression and anxiety affect a significant minority of women during perimenopause and menopause — rates roughly double those seen in premenopausal women of similar ages. The causes are complex and include hormonal shifts, disrupted sleep, and life stressors, but vitamin D deficiency is an additional contributing factor worth addressing.
Vitamin D receptors are present in brain regions involved in mood regulation, including the prefrontal cortex and hippocampus. Calcitriol influences the production of serotonin and dopamine, and vitamin D deficiency is associated with higher inflammatory markers — chronic low-grade inflammation being increasingly linked to depression.
The evidence from clinical trials is mixed: large RCTs such as the VITAL trial (2019) found no significant reduction in depression scores overall, but effects were more noticeable in people who started with genuine deficiency. For postmenopausal women — who are both more likely to be deficient and experiencing mood changes — correcting a low vitamin D level is a reasonable and low-risk step as part of managing this.
Vitamin D and cardiovascular risk
Cardiovascular disease risk rises significantly after menopause, partly because oestrogen has protective effects on blood vessel function that decline with it. Vitamin D deficiency has been independently associated with elevated blood pressure, unfavourable lipid profiles, and higher rates of cardiovascular events in observational studies.
The evidence from supplementation trials on cardiovascular outcomes is not conclusive — the VITAL trial found no significant cardiovascular benefit from 2,000 IU D3 supplementation over 5 years. However, correcting an existing deficiency remains clinically appropriate given the overall health implications, and reducing deficiency-associated inflammation may have indirect benefits on cardiovascular risk markers.
Vitamin D and genitourinary health
Genitourinary syndrome of menopause (GSM) — a cluster of symptoms including vaginal dryness, discomfort, and recurrent urinary tract infections — affects up to 50% of postmenopausal women. Vitamin D receptors are present in the urogenital epithelium, and emerging research suggests vitamin D may support the health and integrity of vaginal and urinary tract tissue.
A 2020 study in Maturitas found that postmenopausal women with GSM had significantly lower serum vitamin D levels than asymptomatic controls, and that correction of deficiency was associated with improvement in some genitourinary symptoms. This is a developing area of research and not sufficient basis for treating GSM with vitamin D alone — but it is another reason to ensure adequate levels are maintained.
How much vitamin D do menopausal women need?
The NHS recommends that all UK adults take a supplement containing 400 IU of vitamin D3 daily from October to March. This is a minimum, not an optimal target — particularly for postmenopausal women, who are at higher risk of deficiency and its consequences.
Most research on bone outcomes in postmenopausal women used doses of 800–2,000 IU daily. NICE recommends 800–1,000 IU daily for adults over 65 specifically to reduce falls and fracture risk. For women who are confirmed deficient (serum 25(OH)D below 25 nmol/L), a GP may recommend higher loading doses to correct the deficiency more quickly, followed by a lower maintenance dose.
Vitamin D3 (cholecalciferol) is more effective than D2 (ergocalciferol) at raising and maintaining serum levels — choose D3 wherever possible.
A blood test for serum 25-hydroxyvitamin D is the only reliable way to know your current level. In the UK, this can be requested through your GP or obtained through private testing services (Medichecks, Thriva) via a home finger-prick kit from around £30–40. Testing before supplementing — rather than supplementing blind — allows you to choose the right dose and monitor whether it’s working.
Vitamin D alongside other nutrients for menopausal bone health
Vitamin D doesn’t work in isolation for bone protection. Key nutrients to ensure alongside it include:
- Calcium: 700mg daily is the UK reference intake for adults; the SACN recommend 1,000mg for postmenopausal women not receiving hormone replacement therapy. Dietary sources (dairy, fortified plant milks, leafy greens) are preferred over high-dose calcium supplements given the cardiovascular uncertainty around supplemental calcium.
- Vitamin K2 (MK-7): Activates osteocalcin and MGP, directing calcium into bone and away from arteries. Most effective when taken alongside D3.
- Magnesium: Required for both activation steps that convert vitamin D to calcitriol. Deficiency impairs vitamin D function even when serum D appears adequate.
Our Vitamin D3 K2 MK-7 supplement addresses the D3 and K2 combination in a single daily formulation with an MCT oil base for fat-soluble absorption.
Frequently asked questions
Why are postmenopausal women more at risk of vitamin D deficiency?
Several factors converge: oestrogen decline reduces the efficiency of vitamin D activation in the kidneys, skin synthesis of D3 decreases with age, and kidney function involved in the final activation step also declines. In the UK, the October–March window of insufficient UVB adds a seasonal layer — making supplementation essential for most postmenopausal women through winter months.
How does vitamin D protect bones during menopause?
Vitamin D is essential for absorbing calcium from the gut. Without adequate vitamin D, calcium absorption drops significantly — and insufficient calcium causes the body to draw it from bone, accelerating bone loss. Combined with vitamin K2 (which directs calcium into bone and away from arteries), adequate vitamin D is a key part of reducing osteoporosis risk during and after menopause.
Can vitamin D help with mood changes during menopause?
Vitamin D receptors are present in brain areas involved in mood regulation, and deficiency is associated with higher rates of depression and anxiety. Evidence from clinical trials is mixed — large studies show modest effects overall. But for postmenopausal women who are deficient, correcting that deficiency may support mood alongside other approaches. It is not a treatment for clinical depression.
How much vitamin D should a menopausal woman take?
The NHS minimum recommendation is 400 IU daily from October to March for all UK adults. Most research on postmenopausal bone health used 800–2,000 IU daily. NICE recommends 800–1,000 IU for adults over 65. The right dose depends on your current serum level — a blood test for 25(OH)D is the most useful starting point. Vitamin D3 is preferred over D2.
Should I take vitamin D3 with vitamin K2 during menopause?
Yes, this combination is well-supported for bone health. Vitamin D3 drives calcium absorption, but K2 is needed to activate the proteins that direct that calcium into bone (osteocalcin) and prevent it from depositing in blood vessels (Matrix Gla Protein). For postmenopausal women with elevated bone loss risk, the D3+K2 combination addresses both absorption and calcium routing — making it more effective than D3 alone.
When is the best time to take vitamin D during menopause?
Vitamin D3 is fat-soluble and is best absorbed when taken with a meal containing fat. There is no strong evidence that morning versus evening timing significantly affects outcomes, though some people find evening doses disrupt sleep. Consistency of timing and daily intake matters more than the specific hour. If you notice any effect on sleep onset when taking D3 in the evening, switch to morning dosing.
References
- Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Practice & Research Clinical Endocrinology & Metabolism. 2011;25(4):585–591. doi:10.1016/j.beem.2011.05.002
- Bischoff-Ferrari HA, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomised controlled trials. JAMA. 2005;293(18):2257–2264. doi:10.1001/jama.293.18.2257
- Sowers MF, et al. Relationship between bone mass and mineral metabolism in the perimenopausal period. Maturitas. 1992;14(3):175–185. doi:10.1016/0378-5122(92)90103-4
- Anglin RES, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. British Journal of Psychiatry. 2013;202(2):100–107. doi:10.1192/bjp.bp.111.106666
- Ascenzi F, et al. Vitamin D in genitourinary syndrome of menopause: a systematic review. Maturitas. 2021;152:24–32. doi:10.1016/j.maturitas.2021.06.004
- National Institute for Health and Care Excellence (NICE). Vitamin D: supplement use in specific population groups. PH56, 2014.
This article is for informational purposes only and does not constitute medical advice. If you are experiencing symptoms of vitamin D deficiency or are concerned about bone health during menopause, speak with your GP. Do not begin high-dose supplementation without medical guidance.
